XML 48 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Quarterly Results of Operations (unaudited)
 12 Months Ended
Dec. 31, 2022
Quarterly Financial Data [Abstract]  
Quarterly Results of Operations (unaudited) Quarterly Results of Operations (unaudited)
The unaudited consolidated quarterly results of operations (in thousands, except per share data) were as follows:

For the Three Months Ended
December 31September 30June 30March 31
2022
Total revenue$382,432 $352,585 $319,939 $297,057 
Total operating expenses384,310339,634324,572299,855
Net income (loss) from continuing operations(11,349)2,123(4,125)(5,350)
Net loss from discontinued operations, net of tax— — (463)— 
Net income (loss) attributable to common shareholders of Evolent Health, Inc.(11,349)2,123(4,588)(5,350)
Income (loss) per common share
Basic and diluted
For the Three Months Ended
December 31September 30June 30March 31
Continuing operations$(0.11)$0.02 $(0.05)$(0.06)
Discontinued operations— — — — 
2021
Total revenue$248,358 $222,471 $222,057 $215,071 
Total operating expenses260,572229,052229,728231,016
Net income (loss) from continuing operations3,053(13,040)(9,107)(11,190)
Net income (loss) from discontinued operations, net of tax(8,700)— — 1,383
Net loss attributable to common shareholders of Evolent Health, Inc.(5,647)(13,040)(9,107)(9,807)
Income (loss) per common share
Basic and diluted
Continuing operations$0.03 $(0.15)$(0.11)$(0.13)
Discontinued operations(0.09)— — 0.01